These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 32241961)

  • 1. Renin-angiotensin-aldosterone system blockade is associated with higher risk of contrast-induced acute kidney injury in patients with diabetes.
    Ma M; Wan X; Gao M; Pan B; Chen D; Sun Q; Zhang M; Zhou C; Li T; Pan H; Shao W; Liu Z; Chen Y; Cao C
    Aging (Albany NY); 2020 Apr; 12(7):5858-5877. PubMed ID: 32241961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study.
    Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY
    Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Renin-Angiotensin-Aldosterone System Blockade Medications on Contrast-Induced Nephropathy in Patients Undergoing Coronary Angiography: A Meta-Analysis.
    Wu Z; Zhang H; Jin W; Liu Y; Lu L; Chen Q; Zhang R
    PLoS One; 2015; 10(6):e0129747. PubMed ID: 26083525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of renin-angiotensin-system blockers on contrast-medium-induced acute kidney injury after coronary angiography.
    Goo JJ; Kim JJ; Kang JH; Kim KN; Byun KS; Kim MK; Kim TI
    Korean J Intern Med; 2014 Mar; 29(2):203-9. PubMed ID: 24648803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of renin-angiotensin-aldosterone system-blocking agents on the risk of contrast-induced acute kidney injury: a prospective study and meta-analysis.
    Peng F; Su J; Lin J; Niu W
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):262-8. PubMed ID: 25502308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of renin-angiotensin system blockers on contrast-induced acute kidney injury in patients with normal or mild-to-moderate reduced kidney function undergoing coronary angiography: A systematic review and meta-analysis.
    Yamada T; Fujisaki T; Chopra N; Yamaji T; Azushima K; Kobayashi R; Kinguchi S; Urate S; Suzuki T; Abe E; Wakui H; Tamura K; Steinberg D
    Clin Nephrol; 2020 Nov; 94(5):227-236. PubMed ID: 32870151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of renin-angiotensin-aldosterone system blockade therapy on incidence of contrast-induced nephropathy in patients with chronic kidney disease.
    Spatz C; Saadulla L; Lapsiwala A; Parhizgar A; Ghahramani N
    Iran J Kidney Dis; 2012 Nov; 6(6):432-6. PubMed ID: 23146980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EVALUATING THE PRESCRIPTION OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS OR RECEPTOR BLOCKERS IN PATIENTS WITH DIABETES IN JORDAN.
    Mayyas F; Bataineh W; Jarab A
    Endocr Pract; 2017 Nov; 23(11):1289-1296. PubMed ID: 28816537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of renin-angiotensin-aldosterone system-acting agents: a cross-sectional study.
    Farcas A; Leucuta D; Bucsa C; Mogosan C; Dumitrascu D
    Int J Clin Pharm; 2016 Dec; 38(6):1390-1397. PubMed ID: 27677980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of chronic usage of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on contrast-induced nephropathy in low-risk patients [corrected].
    Barış N; Özpelit E; Doğan NB; Kangül H; Gül S; Akdeniz B; Güneri S
    Anadolu Kardiyol Derg; 2013 May; 13(3):245-50. PubMed ID: 23261803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of withdrawing vs continuing renin-angiotensin blockers on incidence of acute kidney injury in patients with renal insufficiency undergoing cardiac catheterization: Results from the Angiotensin Converting Enzyme Inhibitor/Angiotensin Receptor Blocker and Contrast Induced Nephropathy in Patients Receiving Cardiac Catheterization (CAPTAIN) trial.
    Bainey KR; Rahim S; Etherington K; Rokoss ML; Natarajan MK; Velianou JL; Brons S; Mehta SR;
    Am Heart J; 2015 Jul; 170(1):110-6. PubMed ID: 26093871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rate and Outcome of Acute Kidney Injury Following Hip Fracture Surgery in Diabetic Older Patients Treated with Renin-Angiotensin-Aldosterone Antagonists.
    Frenkel Rutenberg T; Bdeir A; Rozen-Zvi B; Rosenthal Y; Velkes S; Weiss A; Beloosesky Y
    Drugs Aging; 2019 Jul; 36(7):667-674. PubMed ID: 30949984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between dual RAAS inhibition and risk of acute kidney injury and hyperkalemia in patients with diabetic kidney disease: a systematic review and meta-analysis.
    Whitlock R; Leon SJ; Manacsa H; Askin N; Rigatto C; Fatoba ST; Farag YMK; Tangri N
    Nephrol Dial Transplant; 2023 Oct; 38(11):2503-2516. PubMed ID: 37309038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of RAAS Blockers on Contrast-Induced Nephropathy in Patients With Renal Insufficiency: A Meta-Analysis.
    Huang Y; Zhang S; Liu M; Zhong X; Lin Y; Xiong Z; Fan Y; Zhou H; Sun X; Guo Y; Xu X; Li Y; Yang D; Zhuang X; Liao X
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):692-697. PubMed ID: 32889964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angioedema related to Angiotensin inhibitors.
    Knecht SE; Dunn SP; Macaulay TE
    J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of renin angiotensin system inhibitor on 3-year clinical outcomes in acute myocardial infarction patients with preserved left ventricular systolic function: a prospective cohort study from Korea Acute Myocardial Infarction Registry (KAMIR).
    Kim KH; Choi BG; Rha SW; Choi CU; Jeong MH;
    BMC Cardiovasc Disord; 2021 May; 21(1):251. PubMed ID: 34020593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Lim S; Choo EH; Choi IJ; Ihm SH; Kim HY; Ahn Y; Chang K; Jeong MH; Seung KB
    J Korean Med Sci; 2019 Nov; 34(45):e289. PubMed ID: 31760711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention.
    Choi SY; Choi BG; Rha SW; Byun JK; Shim MS; Li H; Mashaly A; Choi CU; Park CG; Seo HS; Oh DJ; Jeong MH;
    Int J Cardiol; 2017 Dec; 249():48-54. PubMed ID: 28867244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.
    St Peter WL; Odum LE; Whaley-Connell AT
    Pharmacotherapy; 2013 May; 33(5):496-514. PubMed ID: 23576066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Retrospective Study from 2 Centers in China on the Effects of Continued Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Patients with Hypertension and COVID-19.
    Wang Z; Zhang D; Wang S; Jin Y; Huan J; Wu Y; Xia C; Li Z; Qi X; Zhang D; Han X; Zhu X; Qu Y; Wang Q
    Med Sci Monit; 2020 Sep; 26():e926651. PubMed ID: 32969367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.